The expression of B7-H3/B7-H4 in renal cell carcinoma is associated with poor clinical and pathological features, including tumor size, stage and grade, and B7-H3/B7-H4 expression is also associated with poor prognosis (95, 96). This evidence concerns the gene CD276 and neoplasm.